Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 5Breast 2Other 1

Conditions

Overweight 1Obesity 1Neoplasms 1Endometrial Neoplasms 1Endometrial Hyperplasia 1

Interventions

Tirzepatide 3Methods 3Resistance Training 2Progestins 2Nutrition Assessment 2Megestrol Acetate 2Counseling 2semaglutide 1atezolizumab 1Yoga 1Tablets 1TIC10 compound 1Surveys and Questionnaires 1Sampling Studies 1Robotic Surgical Procedures 1Psychology, Positive 1Medroxyprogesterone Acetate 1Magnetic Resonance Spectroscopy 1Letrozole 1Laparoscopy 1LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1Hysteroscopy 1Estrogen Replacement Therapy 1Early Intervention, Educational 1Diet Therapy 1Dehydroepiandrosterone 1Body Weight Maintenance 1Blood Specimen Collection 1Blood Glucose Self-Monitoring 1Bariatric Surgery 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Endometrial Neoplasms × Hysteroscopy × Other × Clear all
NCT07462663 2026-05-13

SHAPE-ENDO

Hospital Universitari de Bellvitge

Phase 4 Not yet recruiting
82 enrolled
GynecologicOther

Endometrial Hyperplasia, Neoplasms, Obesity, Endometrial Neoplasms, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡